ArticlePharmacoEconomics - open2023

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis.

Andrew Khair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.